2-127307698-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001371910.2(MAP3K2):ā€‹c.1741A>Gā€‹(p.Lys581Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,597,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000072 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000028 ( 0 hom. )

Consequence

MAP3K2
NM_001371910.2 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.94
Variant links:
Genes affected
MAP3K2 (HGNC:6854): (mitogen-activated protein kinase kinase kinase 2) The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0700129).
BS2
High AC in GnomAd4 at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAP3K2NM_001371910.2 linkuse as main transcriptc.1741A>G p.Lys581Glu missense_variant 17/17 ENST00000682094.1 NP_001358839.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAP3K2ENST00000682094.1 linkuse as main transcriptc.1741A>G p.Lys581Glu missense_variant 17/17 NM_001371910.2 ENSP00000507315.1 Q9Y2U5

Frequencies

GnomAD3 genomes
AF:
0.0000592
AC:
9
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000903
AC:
2
AN:
221428
Hom.:
0
AF XY:
0.00000838
AC XY:
1
AN XY:
119298
show subpopulations
Gnomad AFR exome
AF:
0.000150
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000277
AC:
4
AN:
1444820
Hom.:
0
Cov.:
31
AF XY:
0.00000419
AC XY:
3
AN XY:
716820
show subpopulations
Gnomad4 AFR exome
AF:
0.0000601
Gnomad4 AMR exome
AF:
0.0000237
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.06e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.0000940
AC XY:
7
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000658
Hom.:
0
Bravo
AF:
0.0000756
ESP6500AA
AF:
0.000715
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 04, 2024The c.1741A>G (p.K581E) alteration is located in exon 16 (coding exon 16) of the MAP3K2 gene. This alteration results from a A to G substitution at nucleotide position 1741, causing the lysine (K) at amino acid position 581 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.073
T;T
Eigen
Benign
-0.23
Eigen_PC
Benign
0.020
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.88
.;D
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.070
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.20
N;N
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
0.040
N;N
REVEL
Benign
0.047
Sift
Benign
0.72
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.085
MVP
0.34
MPC
0.44
ClinPred
0.26
T
GERP RS
5.7
Varity_R
0.073
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372895759; hg19: chr2-128065274; API